Validity of change in DSM-5 ADHD age of onset criterion confirmed

Posted By on July 16, 2014

A recent study published in the July 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry confirms the validity of the DSM-5 change to the age of onset criterion for… [READ MORE HERE]

Source: ADHD News Today

Validity of change in DSM-5 attention-deficit/hyperactivity disorder (ADHD) age of onset criterion confirmed

Posted By on July 15, 2014

A recent study confirms the validity of the DSM-5 change to the age of onset criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). In DSM-5, age of onset criterion for ADHD, previously set at 7 in DSM-IV, has been raised to 12. As explained in DSM-5, age of onset is now set at 12, rather than an earlier age, to reflect the importance of clinical presentation during childhood for accurate diagnosis, while also acknowledging the difficulties in establishing precise childhood onset retrospectively. [READ MORE HERE]

Source: Science Daily

Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment

Posted By on July 11, 2014

Over the last 60 years, the US Food and Drug Administration approved 20 medications for attention deficit/hyperactivity disorder based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers report. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval process. [READ MORE HERE]

Source: Science Daily

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use like in ADHD

Posted By on July 11, 2014

Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to… [READ MORE HERE]

Source: ADHD News Today

Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use like in ADHD

Posted By on July 11, 2014

Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to… [READ MORE HERE]

Source: ADHD News Today